SCHEMBL9436244

SCHEMBL9436244

Cc1[nH]cnc1CS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11073320 0.98
SCHEMBL2830891 0.78
SCHEMBL4905447 0.76
SCHEMBL8014968 0.76
SCHEMBL5791428 0.76
SCHEMBL10376001 0.76
SCHEMBL10964788 0.76
SCHEMBL711376 0.76
Hydrochloric Acid SCHEMBL917 0.74
Hydrochloric Acid SCHEMBL11527267 0.74 TDP1 (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4200761-A Process for preparing N-cyano-N'methyl-N\"-{2-[(4-methyl-5-imidazolyl)-methylthio]-ethyl} guanidine LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) 1980-04-29 US claimed
EP-0279161-B1 A process for the preparation of cimetidine LEK TOVARNA FARMACEVTSKIH (SI) 1994-01-05 EP disclosed
EP-0117345-B1 AMINOPYRIMIDINONES AS HISTAMINE H2-ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-02-28 EP disclosed
US-4855439-A Process for the preparation of cimetidine LEK (YU) 1989-08-08 US disclosed
US-4808589-A Pyrimidone derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1989-02-28 US disclosed
EP-0279161-A2 A process for the preparation of cimetidine LEK, tovarna farmacevtskih in kemicnih izdelkov, n.sol.o. (SI) 1988-08-24 EP disclosed
US-4540699-A N-Substituted pyridinones having histamine H2 -antagonist activity SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-09-10 US disclosed
EP-0117345-A2 Aminopyrimidinones as histamine H2-antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-09-05 EP disclosed
US-4447621-A Use of N-cyano-N'-methyl-N\"-[2-(5-methyl-4-imidazolylmethyldithio)ethyl]guanidine in the preparation of cimetidine SK&F LAB CO. (US) 1984-05-08 US disclosed
EP-0087274-A2 Pyrimidone derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-08-31 EP disclosed
US-4374996-A Disulfide intermediate for cimetidine SK & F LAB CO. (US) 1983-02-22 US disclosed
US-4200761-A Process for preparing N-cyano-N'methyl-N\"-{2-[(4-methyl-5-imidazolyl)-methylthio]-ethyl} guanidine LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) 1980-04-29 US disclosed
US-4200761-A Process for preparing N-cyano-N'methyl-N\"-{2-[(4-methyl-5-imidazolyl)-methylthio]-ethyl} guanidine LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, N.SOL.O. (YU) 1980-04-29 US disclosed